PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNX Development
NX Development
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
GleolanAminolevulinic acid2017-06-062028-2040
Actinic keratosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aminolevulinic acid
infections
,
communicable diseases
,
healthy volunteers/patients
,
wound infection
,
surgical wound infection
,
prostheses and implants
,
prosthesis-related infections
,
pain
,
lung neoplasms
,
oligodendroglioma
,
mycoses
,
mycosis fungoides
,
dermatitis
,
seborrheic dermatitis
,
ulcerative colitis
,
colitis
,
ulcer
,
oral leukoplakia
,
sarcoma
,
neoplasms
,
squamous cell carcinoma
,
photochemotherapy
,
astrocytoma
,
nervous system neoplasms
,
basal cell nevus syndrome
,
leukoplakia
,
central nervous system neoplasms
,
syndrome
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
phototoxic dermatitis
,
uterine cervical dysplasia
,
lymphoma
,
erythroplasia
,
onychomycosis
,
facies
,
gliosarcoma
,
head and neck neoplasms
,
squamous intraepithelial lesions
,
squamous intraepithelial lesions of the cervix
,
malignant mesothelioma
,
mesothelioma
,
malaria
,
cervical intraepithelial neoplasia
,
graft vs host disease
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
bronchiolitis obliterans syndrome
,
crohn disease
,
mouth neoplasms
,
aggressive fibromatosis
,
colonic neoplasms
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
skull base neoplasms
,
vulvar neoplasms
,
diffuse intrinsic pontine glioma
,
colorectal neoplasms
,
glioblastoma
,
brain neoplasms
,
acne vulgaris
,
basal cell neoplasms
,
carcinoma in situ
,
urinary bladder neoplasms
,
recurrence
,
precancerous conditions
,
warts
,
skin diseases
,
skin aging
,
breast neoplasms
,
squamous cell neoplasms
,
non-muscle invasive bladder neoplasms
,
postoperative complications
,
arthroscopy
,
shoulder injuries
,
phototherapy
,
propionibacterium acnes
,
male breast neoplasms
,
meningioma
,
transitional cell carcinoma
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
actinic keratosis
,
keratosis
,
glioma
,
carcinoma
,
basal cell carcinoma
,
skin neoplasms
,
bowen's disease
,
cheilitis
,
rosacea
,
hutchinson's melanotic freckle
,
lentigo
,
neoplasm metastasis
,
type 2 diabetes mellitus
,
covid-19
,
sars-cov-2
,
erythropoietic porphyria
,
porphyrias
,
sleep initiation and maintenance disorders
,
psychological adaptation
,
irritable mood
,
rectal fistula
,
fistula
,
pituitary neoplasms
,
adenoma
,
pituitary diseases
,
critical illness
,
condylomata acuminata
,
diabetes mellitus
,
leg ulcer
,
nevus
,
pigmented nevus
,
porphyria cutanea tarda
,
acute intermittent porphyria
,
erythropoietic protoporphyria
,
anemia
,
iron-deficiency anemia
,
deficiency diseases
,
iron deficiencies
,
hereditary coproporphyria
,
hepatic porphyrias
,
wounds and injuries
,
bone fractures
,
vulvar lichen sclerosus
,
lichen sclerosus et atrophicus
,
hypertrophic cicatrix
,
keloid
,
residual neoplasm
,
primitive neuroectodermal tumors
,
neuroepithelial neoplasms
,
neuroectodermal tumors
,
papillomavirus infections
,
respiratory tract infections
,
non-small-cell lung carcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use